Source link : https://newshealth.biz/health-news/novel-agent-promising-for-refractory-ulcerative-colitis/
Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ulcerative colitis patients in two phase 3 trials. Medscape Medical News Source link : https://www.medscape.com/viewarticle/novel-agent-promising-refractory-ulcerative-colitis-2025a1000rc4?src=rss Author : Publish date : 2025-10-10 08:08:00 Copyright for syndicated content belongs to the linked Source.
The post Novel Agent Promising for Refractory Ulcerative Colitis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-10 08:08:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8